Acorda Therapeutics

1 follower

‌

Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Ron Cohen

President & CEO

Ron Cohen

Collapse

Lauren Sabella

COO

Michael Gesser

CFO

Kerry Clem

Chief Commercial Officer

Neil Belloff

General Counsel

Denise Duca

Executive Vice President, Human Resources

Peter S. Carbone

Senior Vice President, Quality

David Squillacote

VP & Head Of Medical Affairs

Lynn Carroll

Vice President Marketing

Elizabeth J. Gorman

Senior Vice President, Legal And Compliance Officer

Michael Russo

Vice President- Digital Strategy & Innovation

Pasqual Zottola

Vice President Information Technology

Teams

View all

Leadership Team

5 members

CEO and Executive Team

3 members

Discover similar companies

Kymera Therapeutics

3 followers

Cartesian Therapeutics

1 follower

Tempus Labs

12 followers

Ultragenyx Pharmaceutical

5 followers

Biogen

92 followers